Skip to main content

The science
behind Qured

We’re powering longer lives with cutting-edge technology and clinician-led support

Personalised testing plans that evolve with you

We build your personalised testing plan using a combination of clinical data, your family medical history and personal risk factors. Your health profile and previous test results help our algorithm update your plan to recommend the most relevant and impactful tests as your health changes over time.

Victoria
James
Jessica
Man using the TAP® II device

A new standard for blood collection

The innovative TAP® II blood collection device takes blood from the upper arm using microneedles that are thinner than an eyelash for a truly pain-free testing experience. You'll collect your sample in just a few minutes, then post it to our UKAS-accredited labs for a full analysis. One of our health advisors will guide you through the process via video call from the comfort of your home, to make sure you take your test successfully.

Supported by clinicians, driven by data

Using cutting-edge diagnostic technology, we’re able to provide accurate, reliable test results that are broken down into simple, digestible information in the Qured app. Every time you take a new test, one of our clinicians will talk you through the results, giving you actionable advice and suggested next steps. If we spot anything that needs more investigation, we’ll set up a referral to your private medical insurance provider or NHS GP.

We’ve all got a chance of developing specific illnesses, so finding out about this earlier can make all the difference. When we personalise testing plans for you, we’re more likely to pick up conditions you’re at risk of before you develop any symptoms, and before it leads to a life-changing event.

Dr Kishan VithlaniMedical Director and GP

What we test for, and why

Early Cancer Screening

Detect before the symptoms

Prostate cancer accounts for 27% of all male cancer cases in the UK. Our prostate cancer screening measures prostate-specific antigen levels taken from a blood sample, which, combined with risk factors and family history, helps provide a reliable indicator of prostate issues.

54% of bowel cancer cases in the UK are preventable. Our bowel cancer test is a faecal immunochemical test, which looks for traces of blood in a stool sample. These may not be visible to the human eye but can be a sign of bowel cancer.

79% of lung cancer cases in the UK are preventable. Our early lung cancer detection test measures the levels of antibodies related to lung cancer cells in the blood. These may be detectable before symptoms and provide a reliable indicator of potential lung cancer.

Nearly 100% of cervical cancer cases are preventable. Cervical screening can identify the presence of high-risk forms of human papillomavirus (HPV) through a vaginal self-swab. This doesn’t always mean someone will develop cervical cancer, but it helps identify those at a higher risk or those with precancerous changes.

98% of people diagnosed with breast cancer at its earliest stage survive for 5+ years, dropping to 26% when diagnosed at its latest stage. Regular self-examination ensures people with breasts are used to how they should feel and can detect when something doesn’t feel right, for example, a lump, swelling, or discomfort. If an abnormality is detected, we’ll provide a referral for further investigations to increase the chances of identifying any pre-cancerous or early cancer changes.

Testicular cancer is most common in males aged 30-34. Regular self-examination ensures people with testicles are used to how their scrotum and testes should feel and can detect when something doesn’t feel right, for example, a lump or significant change in shape and size. If an abnormality is detected, we’ll provide a referral for further investigations to increase the chances of identifying any pre-cancerous or early cancer changes.

Pre-emptive Fertility Testing

Plan for the future

1 in 7 heterosexual couples struggles to conceive, evenly split between males and females. Our female fertility profile looks at hormones such as FSH, Oestradiol, AMH and ovulation testing to help identify potential issues early on, so women can make data-driven decisions about starting a family.

Around 7% of men in the UK are affected by infertility. Our male fertility profile checks testosterone levels and includes semen analysis to provide clarity on male reproductive health.

Screening for common STIs such as gonorrhoea and chlamydia is vital to any fertility screening, as they can often be present without any symptoms. Both can have a major impact on reproductive health and can cause complications for both the mother and baby during pregnancy.

The average age for women becoming menopausal is 51, but 7% will enter menopause early, between 40 and 45. Our menopause profile combines essential hormone tests to measure FSH, Oestradiol and Luteinising hormone with GP support to discuss the transition and any symptoms to help menopausal or peri-menopausal women care best for their health.

Health Foundations

Stay healthy everyday

24% of men and 22% of women in the UK are Vitamin D deficient, causing symptoms like fatigue, mood changes and muscle weakness. Our Vital Vitamins test measures essential vitamin and nutrient levels, including Vitamin D, B12, B9, Iron and magnesium, to provide an overall picture of wellbeing and identify where supplements or diet changes may be needed.

Over 50% of UK adults have high cholesterol levels, but many are unaware they have it. 90% of liver disease is preventable, yet it's the third biggest cause of premature death. Our Organ and Body Function test checks critical health markers, including cholesterol levels and kidney, liver and thyroid functions, to predict and prevent major illness in the future.

Over 1 million people in the UK live with undiagnosed Type 2 diabetes. For individuals at a higher risk of diabetes, our blood test measures HbA1c levels - an individual's average blood sugar level for the past three months, which can indicate whether they are pre-diabetic or have diabetes. For lower-risk individuals, we provide a urine test that checks for the presence of glucose.

Every 3 minutes, someone in the UK dies from a heart-related disease. Our Cardiovascular Health check measures the level of high-sensitivity C-reactive protein (hsCRP) in the blood, which corresponds to low-level inflammation and atherosclerosis. This helps identify future risks of cardiovascular disease in healthy individuals.

The average age for women becoming menopausal is 51, but 7% will enter menopause early, between 40 and 45. Our menopause profile combines essential hormone tests to measure FSH, Oestradiol and Luteinising hormone with GP support to discuss the transition and any symptoms to help menopausal or peri-menopausal women care best for their health.

Discover what Qured can do for your business

We’ve delivered innovative healthcare benefits to 400 leading businesses, supporting a million customers. Find out what we can do for your people.